Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial-Reference-Cited by-同舟云学术

Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial

Published:2019-07 Issue:8 Volume:33 Page:2118-2125
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Cheraghpour Makan¹,Imani Hossein²,Ommi Shahrzad³,Alavian Seyed Moayed⁴,Karimi‐Shahrbabak Elahe⁵,Hedayati Mehdi⁶,Yari Zahra⁷,Hekmatdoost Azita⁷⁸^ORCID

Affiliation:

1. Cancer Research CenterAhvaz Jundishapur University of Medical Sciences Ahvaz Iran

2. Department of Clinical Nutrition, School of Nutritional Sciences and DieteticsTehran University of Medical Sciences (TUMS) Tehran Iran

3. Department of Dietetics and NutritionFlorida International University Miami Florida

4. Baqiyatallah Research Center for Gastroenterology and Liver DiseasesBaqiyatallah University of Medical Sciences Tehran Iran

5. Human Nutrition DepartmentMcGill University Montreal Quebec Canada

6. Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine SciencesShahid Beheshti University of Medical Sciences Tehran Iran

7. Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, National Nutrition and Food Technology Research InstituteShahid Beheshti University of Medical Sciences Tehran Iran

8. Division of GastroenterologyBC Children's Hospital Vancouver British Columbia Canada

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.6406

Reference41 articles.

1. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

2. Antidiabetic effects of hesperidin and naringin in type 2 diabetic rats;Ahmed O. M.;Diabetologia Croatica,2012

3. Effect of Atorvastatin, Vitamin E and C on Nonalcoholic Fatty Liver Disease: Is the Combination Required?

4. The epidemiology of non-alcoholic fatty liver disease

5. Plasma and Hepatic Cholesterol and Hepatic Activities of 3-Hydroxy-3-methyl-glutaryl-CoA Reductase and Acyl CoA: Cholesterol Transferase Are Lower in Rats Fed Citrus Peel Extract or a Mixture of Citrus Bioflavonoids

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of Huatan Qushi Huoxue Fang granules on obese non-alcoholic fatty liver disease: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial;2024-09-04

2. Hesperidin: a flavanone with multifaceted applications in the food, animal feed, and environmental fields;Phytochemistry Reviews;2024-08-21

3. Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial;Cell Reports Medicine;2024-08

4. Herbal treatments for non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials;Advances in Integrative Medicine;2024-08

5. Effects of Hesperidin Supplementation on Cardiometabolic Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials;Nutrition Reviews;2024-07-22